[go: up one dir, main page]

Fomenko et al., 2014 - Google Patents

Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage

Fomenko et al., 2014

View PDF @Full View
Document ID
4885047543668897875
Author
Fomenko I
Sklyarov A
Bondarchuk T
Biletska L
Panasyuk N
Wallace J
Publication year
Publication venue
Stress

External Links

Snippet

Mechanisms of gastric defence under conditions of combined influence of acute stress and non-steroidal anti-inflammatory drugs (NSAIDs) are still poorly studied. The aim of this study was to explore the effects of different types of NSAIDs (naproxen, celecoxib and ATB-346) in …
Continue reading at www.tandfonline.com (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-arylpropionic acids, ethacrynic acid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid

Similar Documents

Publication Publication Date Title
Fomenko et al. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage
Chan et al. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments
Wang et al. The role of H2S bioavailability in endothelial dysfunction
Paul et al. H2S signalling through protein sulfhydration and beyond
Zaorska et al. Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors
Yu et al. Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling
Xu et al. Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response
Matera et al. Oxidation pathway and exacerbations in COPD: the role of NAC
Blackler et al. Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence
Waseem et al. Cisplatin hepatotoxicity mediated by mitochondrial stress
Zanardo et al. Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation
Zhang et al. Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases
Whiteman et al. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising
Flannigan et al. Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis
Cheng et al. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats
Nguyen et al. Dual COX and 5-LOX inhibition by clerodane diterpenes from seeds of Polyalthia longifolia (Sonn.) Thwaites
Sezgin et al. Protective effect of melatonin and 1, 25-dihydroxyvitamin D3 on renal ischemia–reperfusion injury in rats
Garrabou et al. Mitochondrial injury in human acute carbon monoxide poisoning: the effect of oxygen treatment
Magierowska et al. Carbon monoxide (CO) released from tricarbonyldichlororuthenium (II) dimer (CORM-2) in gastroprotection against experimental ethanol-induced gastric damage
Kimura et al. Sulfite protects neurons from oxidative stress
Chattopadhyay et al. Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐and H2S‐releasing hybrid
Fiorucci et al. Activation of the farnesoid‐X receptor protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs in mice
Xu et al. Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage
Sarna et al. The CBS/CSE system: a potential therapeutic target in NAFLD?
Popov An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential